Biora Therapeutics, Inc. (BIOR) Tops Q2 EPS by 9c

Biora Therapeutics, Inc. (NASDAQ: BIOR) reported Q2 EPS of ($0.03), $0.09 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Biora Therapeutics, Inc. (BIOR) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• General Mills posts lower Q1 sales, reaffirms fiscal 2027 targets
• Goldman Sachs Downgrades Bank Mandiri (BMRI:IJ) (PPERF) to Sell, 'Liquidity and capital tightness'